Projected Income Statement: Genpact Limited

Forecast Balance Sheet: Genpact Limited

Forecast Balance Sheet - Genpact Limited
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 756 780 683 573 688 448 -283 -947
Change - 3.17% -12.44% -16.11% 20.07% -34.93% -163.17% -234.63%
Announcement Date 2/11/22 A 2/9/23 A 2/8/24 A 2/6/25 A 2/5/26 A - - -
1USD in Million
Estimates

Cash Flow Forecast: Genpact Limited

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 53.34 50.61 55.42 82.77 78.2 79.43 105 119.9
Change - -5.11% 9.5% 49.34% -5.51% 1.57% 32.22% 14.2%
Free Cash Flow (FCF) 1 640.9 393.1 435.4 532.7 734.7 389 744.7 742
Change - -38.68% 10.77% 22.34% 37.92% -47.05% 91.43% -0.36%
Announcement Date 2/11/22 A 2/9/23 A 2/8/24 A 2/6/25 A 2/5/26 A - - -
1USD in Million
Estimates

Forecast Financial Ratios: Genpact Limited

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 19.19% 18.42% 18.66% 18.54% 18.86% 18.81% 19.29% 19.5%
EBIT Margin (%) 16.48% 16.43% 17.04% 17.07% 17.47% 17.69% 17.92% 18.06%
EBT Margin (%) 12.01% 10.64% 13.45% 14.2% 14.37% 14.62% 14.87% 15.1%
Net margin (%) 9.19% 8.08% 14.1% 10.78% 10.88% 11.17% 11.33% 11.56%
FCF margin (%) 15.94% 8.99% 9.73% 11.17% 14.46% 7.15% 12.77% 11.71%
FCF / Net Income (%) 173.49% 111.22% 68.97% 103.7% 132.97% 64.01% 112.74% 101.34%

Profitability

        
ROA 7.5% 7.1% 13.44% 10.49% 11.91% 11.48% 12.07% 11.71%
ROE 19.8% 18.63% 30.99% 22.15% 26.11% 25.47% 24.11% 21.76%

Financial Health

        
Leverage (Debt/EBITDA) 0.98x 0.97x 0.82x 0.65x 0.72x 0.44x - -
Debt / Free cash flow 1.18x 1.98x 1.57x 1.08x 0.94x 1.15x - -

Capital Intensity

        
CAPEX / Current Assets (%) 1.33% 1.16% 1.24% 1.74% 1.54% 1.46% 1.8% 1.89%
CAPEX / EBITDA (%) 6.91% 6.29% 6.63% 9.37% 8.16% 7.76% 9.34% 9.71%
CAPEX / FCF (%) 8.32% 12.88% 12.73% 15.54% 10.64% 20.42% 14.1% 16.16%

Items per share

        
Cash flow per share 1 3.598 2.366 2.677 3.411 4.602 3.182 4.665 5.73
Change - -34.24% 13.14% 27.41% 34.92% -30.85% 46.62% 22.83%
Dividend per Share 1 0.43 0.5 0.55 0.61 0.68 0.7612 0.8368 0.9166
Change - 16.28% 10% 10.91% 11.48% 11.94% 9.93% 9.54%
Book Value Per Share 1 10.04 10.37 9.864 13.68 14.43 15.87 20.26 25.3
Change - 3.35% -4.89% 38.71% 5.49% 9.99% 27.65% 24.87%
EPS 1 1.91 1.88 3.41 2.85 3.13 3.562 3.939 4.434
Change - -1.57% 81.38% -16.42% 9.82% 13.79% 10.59% 12.58%
Nbr of stocks (in thousands) 188,060 183,258 181,412 176,361 172,414 167,227 167,227 167,227
Announcement Date 2/11/22 A 2/9/23 A 2/8/24 A 2/6/25 A 2/5/26 A - - -
1USD
Estimates
2026 *2027 *
P/E 11.7x 10.5x
PBR 2.61x 2.05x
EV / Sales 1.36x 1.14x
Yield 1.83% 2.02%

EPS & Dividend

EPS & Dividend - Genpact Limited


Y-o-Y evolution of P/E

Valuation ratios - P/E - Genpact Limited
 

Year-on-year evolution of the Yield

Valuation ratios - Yield - Genpact Limited
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Genpact Limited
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
41.50USD
Average target price
47.64USD
Spread / Average Target
+14.79%
  1. Stock Market
  2. Stocks
  3. G Stock
  4. Financials Genpact Limited